CSI Market
Sign In | Register

Acutus Medical Inc (AFIB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AFIB Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Acutus Medical Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-9.55
Depreciation & amortization0.30
Amortization of Other Assets0.93
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories2.49
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business-10.81
Share-based Compensation0.46
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-0.22
Finance Lease Right Of Use Asset Amortization0.54
Change In Fair Value Of Warrant Liability And Embedded Derivative-
Change In Fair Value Of Contingent Consideration-
Change In Property Plant And Equipment Converted To Sales-
Payments For Disposal Of Business-
Business Disposition Transaction Costs-
Employer Retention Credit Receivable-
Increase Decrease In Operating Lease Liability-0.53
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-4.05
Increase (Decrease) in Accounts Payable-1.49
Increase (Decrease) in Accrued Liabilities-0.25
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.05
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.03
Discontinued operations-9.46
Net Cash flow from Operating Activities-31.66
Investing Activities
Capital Expenditures-0.11
Sale of Capital Items0.00
Short-term Investments Proceeds3.25
Payments to Acquire Available-for-sale Securities, Debt0.00
Real Estate Investments0.00
Payments To Acquire Research And Development License-
Payments For Direct Costs In Divestiture Of Business-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses18.67
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.34
Net Cash Flow from Investing Activities22.15
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-2.63
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-26.24
Proceeds From Issuance Of Debt And Warrants-
Payments Of Deferred Offering Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents26.20
Payment Of Amendment Consent Fees-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-2.89
Effect of exchange rate on cash flow0.22
Discontinued operations0.00
Free Cash Flow-31.77
Total Cash Flow-12.18
4 historic quarters locked

Sign in to unlock the full Acutus Medical Inc cash flow history.

Sign In Create Free Account

About Acutus Medical Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 14, 2024
  • Source: afib-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-24-047933

Figures are derived from filed reports and may be restated. Historical data is subject to revision.